Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "environment"

814 News Found

ZenMD launches India-focused clinical AI platform for doctors and hospitals
Digitisation | May 21, 2026

ZenMD launches India-focused clinical AI platform for doctors and hospitals

Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients


K J Somaiya contest promotes nursing-led healthcare innovation
Healthcare | May 20, 2026

K J Somaiya contest promotes nursing-led healthcare innovation

The competition received over 42 entries from nursing colleges across Maharashtra


Decoding teleophthalmology role in transforming last-mile eye care in India
Opinion | May 20, 2026

Decoding teleophthalmology role in transforming last-mile eye care in India

By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic


Shaily gets regulatory nod for launch of ShailyPen Neo device technology
Medical Device | May 20, 2026

Shaily gets regulatory nod for launch of ShailyPen Neo device technology

The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval


India’s top scientific minds discuss  preparedness against emerging health threats
Policy | May 19, 2026

India’s top scientific minds discuss preparedness against emerging health threats

Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges


Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge
News | May 19, 2026

Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge

Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels


Lupin debuts in Dow Jones best-in-class indices for ESG performance
News | May 19, 2026

Lupin debuts in Dow Jones best-in-class indices for ESG performance

The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index


Senores Pharma reports 62% rise in FY26 total income to Rs. 664 crore
News | May 15, 2026

Senores Pharma reports 62% rise in FY26 total income to Rs. 664 crore

The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives


Senores Pharma doubles profit as sales surge 62%
News | May 15, 2026

Senores Pharma doubles profit as sales surge 62%

Global specialty pipeline accelerates growth